128 related articles for article (PubMed ID: 33954334)
1. PRPF19 promotes tongue cancer growth and chemoradiotherapy resistance.
He Y; Huang C; Cai K; Liu P; Chen X; Xu YI; Ming Z; Liu Q; Xie Q; Xia X; Sun Y; Luo J; Wei R
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):893-902. PubMed ID: 33954334
[TBL] [Abstract][Full Text] [Related]
2. PRPF19 promotes the proliferation, migration, and inhibits autophagy in prostate cancer by suppressing SLC40A1.
Zhang G; Zhang W; Dan M; Zou F; Qiu C; Sun C
Chin J Physiol; 2023; 66(5):379-387. PubMed ID: 37929350
[TBL] [Abstract][Full Text] [Related]
3. PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA.
Yano K; Takahashi RU; Shiotani B; Abe J; Shidooka T; Sudo Y; Yamamoto Y; Kan S; Sakagami H; Tahara H
J Biol Chem; 2021 Jul; 297(1):100882. PubMed ID: 34144037
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
5. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
6. PRPF19 facilitates colorectal cancer liver metastasis through activation of the Src-YAP1 pathway via K63-linked ubiquitination of MYL9.
Zhou R; Chen J; Xu Y; Ye Y; Zhong G; Chen T; Qiu L
Cell Death Dis; 2023 Apr; 14(4):258. PubMed ID: 37031206
[TBL] [Abstract][Full Text] [Related]
7. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the WD40 domain of human PRPF19.
Zhang Y; Li Y; Liang X; Zhu Z; Sun H; He H; Min J; Liao S; Liu Y
Biochem Biophys Res Commun; 2017 Nov; 493(3):1250-1253. PubMed ID: 28962858
[TBL] [Abstract][Full Text] [Related]
9. YY1-mediated PTEN dephosphorylation antagonizes IR-induced DNA repair contributing to tongue squamous cell carcinoma radiosensitization.
Zhao L; Li R; Qiu JZ; Yu JB; Cao Y; Yuan RT
Mol Cell Probes; 2020 Oct; 53():101577. PubMed ID: 32334006
[TBL] [Abstract][Full Text] [Related]
10. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
11. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
[TBL] [Abstract][Full Text] [Related]
12. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
[TBL] [Abstract][Full Text] [Related]
13. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
[TBL] [Abstract][Full Text] [Related]
14. [In vivo short hairpin RNA interference of vascular endothelial growth factor on drug-resistant tongue cancer cells].
Nong XL; Li H; Xia Y; Li Y; Li JQ; Yang YP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Jan; 46(1):15-9. PubMed ID: 21418939
[TBL] [Abstract][Full Text] [Related]
15. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
16. API5 induces cisplatin resistance through FGFR signaling in human cancer cells.
Jang HS; Woo SR; Song KH; Cho H; Chay DB; Hong SO; Lee HJ; Oh SJ; Chung JY; Kim JH; Kim TW
Exp Mol Med; 2017 Sep; 49(9):e374. PubMed ID: 28883546
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
18. Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Yuan S; Lin LS; Gan RH; Huang L; Wu XT; Zhao Y; Su BH; Zheng D; Lu YG
BMC Cancer; 2020 Jan; 20(1):33. PubMed ID: 31937294
[TBL] [Abstract][Full Text] [Related]
19. Combined Effects of Suberoylanilide Hydroxamic Acid and Cisplatin on Radiation Sensitivity and Cancer Cell Invasion in Non-Small Cell Lung Cancer.
Feng J; Zhang S; Wu K; Wang B; Wong JY; Jiang H; Xu R; Ying L; Huang H; Zheng X; Chen X; Ma S
Mol Cancer Ther; 2016 May; 15(5):842-53. PubMed ID: 26839308
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of PRPF19 immune infiltrates, DNA methylation, senescence-associated secretory phenotype and ceRNA network in bladder cancer.
Wang Y; Wang J; He J; Ji B; Pang Z; Wang J; Liu Y; Ren M
Front Immunol; 2023; 14():1289198. PubMed ID: 38022515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
